Resources for Researchers
The specimen repositories are a collaboration between the ACTG and IMPAACT clinical trial networks to make the large body of specimens collected for HIV research available to investigators.
The ARLG biorepositories were created to aid in the development and evaluation of novel diagnostic tests and laboratory techniques, study mechanisms of resistance, generate preliminary data for study concepts, and support/mentor early-stage investigators pursuing research in the field of antibact
NIAID CEIRS provides the BEI Resources Repository with high-priority reagents from the CEIRS community. Reagents include plasmids, antibodies, proteins, and virus isolates. Reagents not available through BEI can be requested on this page.
Repository of specimens collected as part of the DAIDS VAX004 Clinical Trial.
The Filariasis Research Reagent Resource Center (FR3) maintains oversight of filarial parasites, SOPs, and molecular reagents. FR3 is comprised of two divisions: The Parasite Resource Division and the Molecular Resources Division.
The Human Tissue and Organ Research Resource (HTORR) program provides normal and diseased human tissues to investigators at research centers. HTORR supports the procurement, preservation, and distribution of human tissue and organs for basic and clinical research. While the resource maintains a
The MACS collects and stores a variety of biological specimens. Inventory may be housed at the national level or a subset at the local level. The MACS Center for the Coordination and Analysis of MACS (CAMACS) coordinates and facilitates completion of specimen requests.
Researchers involved with the NIAID Clinical Genomics Program study many diseases of the immune system that are rare and not well understood but often shed light on basic immune function and more common immune disorders.
The National Institutes of Health (NIH) AIDS Reagent Program provides critical research reagents and resources to the scientific community. The ARP acquires, develops, and produces state-of-the-art reagents and provides these reagents at no cost to qualified investigators throughout the world.
The National Institutes of Health (NIH) Tetramer Core Facility (TCF) at Emory University was established in 1999 for the production and distribution to the research community of major histocompatibility complex tetramers and related reagents for the detection of T cell responses to viruses, bacte
The Non-Obese Diabetic (NOD) mouse, which spontaneously develops type 1 diabetes, is a valuable animal model that is used extensively in research exploring the etiology, prevention, and treatment of this disease.
The Nonhuman Primate Reagent Resource is funded by the National Institutes of Health to facilitate the optimal use of nonhuman primate models in biomedical research.
The Primary Immunodeficiency (PI) Diseases Registry collects validated data on all PI diagnoses from patients who give Informed Consent. The de-identified data in the registry is freely disseminated to those with research questions about PI diseases.
The Schistosomiasis Resource Center (SRC) provides three major strains of snails (Biomphalaria glabrata, Bulinus truncatus, and Oncomelania hupensis) and rodents infected with S. haematobium, S.
TrialShare is a transformative approach to data-sharing that enables clinical trial transparency.
The USIDNET Cell Repository, part of the US Immunodeficiency Network, provides a resource of DNA and functional lymphoid cells obtained from patients with various primary immunodeficiency diseases.
The Women's Interagency HIV Study (WIHS) collects and stores a variety of biological specimens. Inventory may be housed at the national level, or a subset at the local level. The WIHS Data Management and Analysis Center (WDMAC) coordinates and facilitates completion of specimen requests.
The WRCEVA program maintains the Emerging Viruses and Arboviruses Reference Collection and provides reagents and support for investigations of virus outbreaks throughout the world.
This resource provides Good Manufacturing Practice (GMP)-quality candidate vaccine viruses for zoonotic influenza, a critical component of global influenza pandemic preparedness.